Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,097 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of concern: Carbon quantum dots as a dual platform for the inhibition and light-based destruction of collagen fibers: implications for the treatment of eye floaters.
Barras A, Sauvage F, de Hoon I, Braeckmans K, Hua D, Buvat G, Fraire JC, Lethien C, Sebag J, Harrington M, Abderrahmani A, Boukherroub R, De Smedt S, Szunerits S. Barras A, et al. Among authors: harrington m. Nanoscale Horiz. 2024 Dec 5. doi: 10.1039/d4nh90078b. Online ahead of print. Nanoscale Horiz. 2024. PMID: 39633547
A type 1 hybrid multi-site randomized controlled trial protocol for evaluating virtual interview training among autistic transition-age youth.
Smith MJ, Merle JL, Baker-Ericzén M, Sherwood K, Bornheimer LA, Ross B, Harrington M, Sharma A, Brown C, Gordon TT, Telfer D, Reese J, Hirst J, Oulvey EA, Dignadice V, Williams ED, Magaña S, Hume K, Sung C, Burke-Miller JK, Smith JD. Smith MJ, et al. Among authors: harrington m. Contemp Clin Trials Commun. 2024 Oct 18;42:101384. doi: 10.1016/j.conctc.2024.101384. eCollection 2024 Dec. Contemp Clin Trials Commun. 2024. PMID: 39525564 Free PMC article.
Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial.
Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Ansari W, Harrington MA, Simón-Campos A, Chew KW, Pypstra R, Rusnak JM. Hammond J, et al. Among authors: harrington ma. Clin Infect Dis. 2024 Nov 11:ciae551. doi: 10.1093/cid/ciae551. Online ahead of print. Clin Infect Dis. 2024. PMID: 39523543
1,097 results